Navigation Links
Mature US and European coronary artery bypass graft device markets will Shrink through 2021
Date:7/11/2013

TORONTO, July 11, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, declines in isolated coronary artery bypass graft (CABG) procedures in the United States and Europe will primarily be attributed to the increasing use of percutaneous coronary intervention (PCI), which is less invasive and offers shorter recovery times. In particular, younger patients or patients with less severe coronary artery disease are increasingly being referred for PCIs.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)  

The average age of patients undergoing CABG procedures is therefore rising, and these patients are more likely to suffer from other heart-related diseases that will also require treatment. As a result, the proportion of CABG surgeries performed at the same time as other procedures, such as open surgical heart valve procedures or surgical ablations, will expand, which will help to sustain overall CABG procedure volumes through 2021.

In the US and Europe, there will be a slight increase in revenues for devices used in endoscopic vessel harvesting (EVH) because they are less invasive compared to traditional vessel harvesting techniques. There are minor differences, however, between the EVH device segments in the two regions. In the US, adoption of EVH devices is already close to saturation; therefore, the shift to premium-priced EVH devices will primarily drive the market.

"In Europe, there is still potential for EVH use to grow because in the past, physicians preferred less expensive traditional methods," said MRG Analyst Tony Su. "However, as patients and surgeons become increasingly aware of the clinical benefits of EVH devices, their use in CABG procedures will expand."

Nonetheless, price competition and budget constraints will continue to hinder the largely mature and commoditized CABG device markets in both regions. Major competitors such as Sorin Group, MAQUET, Medtronic and Terumo will be better positioned to compete in this challenging environment and will likely not be threatened by any new entrants.

Millennium Research Group's US Markets for Coronary Artery Bypass Graft Devices 2013 and European Markets for Coronary Artery Bypass Graft Devices 2013 reports include unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for on-pump coronary artery bypass devices, off-pump coronary artery bypass devices, EVH devices and anastomosis assist devices in the United States, France, Germany, Italy, Spain and the United Kingdom. Supplemental country coverage is also available for Austria, Belgium, the Czech Republic, Denmark, Finland, Greece, Hungary, the Netherlands, Norway, Poland, Portugal, Romania, Sweden, Switzerland and Ukraine, as well as in aggregate for the rest of the European countries.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.comAlex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net 


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Varying Technology and Application Trends Pep up the Mature Research Antibodies Market, Finds Frost & Sullivan
2. Revolutionary Device for Premature Ejaculation Treatment
3. Prolong TM, a New Revolutionary First Line Treatment for Premature Ejaculation is Licensed in Europe
4. Maximizing the Potential of Mature Brands with Key Lifecycle Management Strategies Tailored to the Pharmaceutical Industry
5. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
6. Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
9. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
10. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
11. Mylan Launches Generic Lipitor® in Five European Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 2016 A key trend that ... emergence of new treatments. Cardax, a development stage life ... The therapy is expected to fulfil large unmet medical ... conducting studies to develop new treatments for osteoarthritis. One ... involved in osteoarthritis are being investigated, and early trials ...
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... , May 25,2016 FDA ... near-infrared Cellvizio platform for urological and surgical applications ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... milestone in the US with the 12 th ... Drug Administration (FDA). This new FDA clearance covers ...
Breaking Medicine Technology:
(Date:5/29/2016)... ... May 29, 2016 , ... "With 30 unique self-animating web themed intros and ... of their project," said Christina Austin - CEO of Pixel Film Studios. , ... for use in Final Cut Pro X. Pixel Film Studios’ minimalistic titles allow users ...
(Date:5/28/2016)... ... ... city where’s it’s easy to spot the neon lights of chains serving fast food, one ... a taste for real food. , On May 13, the Best Western Plus ... restaurant focusing on dishes made by hand with wholesome, organic ingredients that are sourced locally ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses ... time to shed lights on the variety of topics detailing why we appreciate nurses ... tackles why this career has gone from being in a major recession to one ...
(Date:5/27/2016)... ... ... Beleza Medspa has initiated a new program to assist active duty ... that Coolsculpting is being used for for more than just cosmetic purposes. ... prescribed body-fat standard, measured by the circumference-based tape method. The tape-test is used ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
Breaking Medicine News(10 mins):